Labcorp Holdings EBITDA Margin 2010-2025 | LH
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Labcorp Holdings (LH) over the last 10 years. The current EBITDA margin for Labcorp Holdings as of March 31, 2025 is .
| Labcorp Holdings EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-03-31 | $13.18B | $1.75B | 13.27% |
| 2024-12-31 | $13.01B | $1.73B | 13.31% |
| 2024-09-30 | $12.71B | $1.35B | 10.65% |
| 2024-06-30 | $12.49B | $1.35B | 10.80% |
| 2024-03-31 | $12.30B | $1.31B | 10.62% |
| 2023-12-31 | $12.16B | $1.30B | 10.71% |
| 2023-09-30 | $11.30B | $1.37B | 12.12% |
| 2023-06-30 | $11.11B | $1.46B | 13.17% |
| 2023-03-31 | $11.00B | $1.60B | 14.50% |
| 2022-12-31 | $11.87B | $1.97B | 16.64% |
| 2022-09-30 | $10.76B | $2.44B | 22.66% |
| 2022-06-30 | $11.96B | $2.88B | 24.12% |
| 2022-03-31 | $12.88B | $3.24B | 25.13% |
| 2021-12-31 | $13.14B | $3.63B | 27.60% |
| 2021-09-30 | $16.56B | $4.56B | 27.57% |
| 2021-06-30 | $16.39B | $5.27B | 32.16% |
| 2021-03-31 | $15.32B | $4.82B | 31.48% |
| 2020-12-31 | $13.98B | $3.53B | 25.27% |
| 2020-09-30 | $12.44B | $2.55B | 20.46% |
| 2020-06-30 | $11.48B | $1.37B | 11.94% |
| 2020-03-31 | $11.59B | $1.41B | 12.12% |
| 2019-12-31 | $11.56B | $1.91B | 16.50% |
| 2019-09-30 | $11.39B | $1.86B | 16.33% |
| 2019-06-30 | $11.29B | $1.85B | 16.40% |
| 2019-03-31 | $11.28B | $1.88B | 16.70% |
| 2018-12-31 | $11.33B | $1.88B | 16.56% |
| 2018-09-30 | $11.29B | $1.91B | 16.89% |
| 2018-06-30 | $11.08B | $1.89B | 17.07% |
| 2018-03-31 | $10.74B | $1.84B | 17.13% |
| 2017-12-31 | $10.31B | $1.84B | 17.83% |
| 2017-09-30 | $9.90B | $1.78B | 17.92% |
| 2017-06-30 | $9.70B | $1.76B | 18.16% |
| 2017-03-31 | $9.60B | $1.79B | 18.69% |
| 2016-12-31 | $9.55B | $1.77B | 18.53% |
| 2016-09-30 | $9.52B | $1.71B | 17.97% |
| 2016-06-30 | $9.42B | $1.69B | 17.98% |
| 2016-03-31 | $9.26B | $1.64B | 17.75% |
| 2015-12-31 | $8.68B | $1.46B | 16.77% |
| 2015-09-30 | $7.89B | $1.38B | 17.50% |
| 2015-06-30 | $7.13B | $1.25B | 17.57% |
| 2015-03-31 | $6.37B | $1.12B | 17.60% |
| 2014-12-31 | $6.01B | $1.15B | 19.15% |
| 2014-09-30 | $5.94B | $1.15B | 19.36% |
| 2014-06-30 | $5.85B | $1.15B | 19.71% |
| 2014-03-31 | $5.80B | $1.17B | 20.16% |
| 2013-12-31 | $5.81B | $1.22B | 21.06% |
| 2013-09-30 | $5.78B | $1.22B | 21.17% |
| 2013-06-30 | $5.73B | $1.22B | 21.33% |
| 2013-03-31 | $5.69B | $1.23B | 21.61% |
| 2012-12-31 | $5.67B | $1.26B | 22.15% |
| 2012-09-30 | $5.63B | $1.29B | 22.86% |
| 2012-06-30 | $5.62B | $1.28B | 22.82% |
| 2012-03-31 | $5.60B | $1.23B | 22.05% |
| 2011-12-31 | $5.54B | $1.18B | 21.36% |
| 2011-09-30 | $5.47B | $1.17B | 21.40% |
| 2011-06-30 | $5.34B | $1.16B | 21.71% |
| 2011-03-31 | $5.18B | $1.20B | 23.12% |
| 2010-12-31 | $5.00B | $1.19B | 23.74% |
| 2010-09-30 | $4.87B | $1.16B | 23.84% |
| 2010-06-30 | $4.78B | $1.16B | 24.28% |
| 2010-03-31 | $4.73B | $1.14B | 23.98% |
| 2009-12-31 | $4.70B | $1.14B | 24.28% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $21.856B | $13.009B |
| Labcorp Holdings Inc. provides laboratory services which helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. Labcorp Holdings Inc., formerly known as LABORATORY CP, is based in BURLINGTON, N.C. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $143.613B | 26.94 |
| Elevance Health (ELV) | United States | $86.883B | 11.21 |
| CVS Health (CVS) | United States | $85.338B | 10.61 |
| Cencora (COR) | United States | $57.283B | 19.93 |
| DiDi Global (DIDIY) | China | $22.826B | 24.25 |
| Natera (NTRA) | United States | $22.577B | 0.00 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.669B | 0.00 |
| Solventum (SOLV) | United States | $12.768B | 13.52 |
| ICON (ICLR) | Ireland | $11.763B | 10.94 |
| CochLear (CHEOY) | Australia | $11.550B | 0.00 |
| Revvity (RVTY) | United States | $11.024B | 18.97 |
| Doximity (DOCS) | United States | $10.503B | 48.63 |
| Viatris (VTRS) | United States | $10.469B | 3.60 |
| HealthEquity (HQY) | United States | $9.059B | 39.68 |
| Avantor (AVTR) | United States | $8.906B | 12.94 |
| Medpace Holdings (MEDP) | United States | $8.572B | 22.77 |
| Sonic Healthcare (SKHHY) | Australia | $8.393B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.340B | 14.38 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.361B | 25.69 |
| BrightSpring Health Services (BTSG) | United States | $3.724B | 34.16 |
| Sotera Health (SHC) | United States | $3.244B | 18.43 |
| Alignment Healthcare (ALHC) | United States | $2.956B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.914B | 37.90 |
| Concentras Parent (CON) | United States | $2.749B | 15.89 |
| Organon (OGN) | United States | $2.610B | 2.77 |
| Ardent Health (ARDT) | United States | $1.881B | 8.02 |
| Premier (PINC) | United States | $1.858B | 14.11 |
| GeneDx Holdings (WGS) | United States | $1.842B | 70.96 |
| Progyny (PGNY) | United States | $1.803B | 39.68 |
| PACS (PACS) | United States | $1.573B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.561B | 31.21 |
| Teladoc Health (TDOC) | United States | $1.203B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.203B | 9.15 |
| Establishment Labs Holdings (ESTA) | $1.083B | 0.00 | |
| CareDx (CDNA) | United States | $1.035B | 16.17 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.011B | 0.00 |
| Agilon Health (AGL) | United States | $0.890B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.826B | 7.73 |
| QDM (QDMI) | Hong Kong, SAR China | $0.763B | 0.00 |
| Nutex Health (NUTX) | United States | $0.679B | 10.28 |
| LifeMD (LFMD) | United States | $0.566B | 0.00 |
| Embecta (EMBC) | United States | $0.559B | 3.76 |
| Enhabit (EHAB) | United States | $0.495B | 40.75 |
| InnovAge Holding (INNV) | United States | $0.478B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.467B | 10.52 |
| SBC Medicals (SBC) | United States | $0.459B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.453B | 0.00 |
| Omada Health (OMDA) | $0.440B | 0.00 | |
| COMPASS Pathways (CMPS) | United Kingdom | $0.411B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.255B | 0.00 |
| Oncology Institute (TOI) | United States | $0.220B | 0.00 |
| Beauty Health (SKIN) | United States | $0.193B | 0.00 |
| KindlyMD (KDLY) | United States | $0.150B | 0.00 |
| DocGo (DCGO) | United States | $0.148B | 24.17 |
| Pheton Holdings (PTHL) | China | $0.114B | 0.00 |
| So-Young (SY) | China | $0.097B | 0.00 |
| KindlyMD (NAKA) | United States | $0.083B | 0.00 |
| OncoCyte (OCX) | United States | $0.076B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.064B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.064B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.060B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.054B | 0.00 |
| Biodesix (BDSX) | United States | $0.042B | 0.00 |
| ModivCare (MODV) | United States | $0.042B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.028B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.013B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |